aTyr Pharma (LIFE) – Hot Corp. News
-
aTyr Pharma (LIFE) Phase 2 Clinical Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications Met Its Primary Endpoint
-
aTyr Pharma (LIFE) Granted FDA Fast Track Status for Resolaris
-
-
-
-
-
-
Back to LIFE Stock Lookup